News Does the Novavax delay augur a COVID vaccine policy change? Statements from HHS suggest new hurdles could be coming for seasonal COVID formulations, though the picture is still unclear.
Patients Protecting the immunocompromised: Preventative measures agai... COVID-19 vaccines are not as effective in immunocompromised individuals as they are in the general population, due to an inability to produce a robust protective response to the vaccine.
Views & Analysis Not just COVID-19 vaccines: 5 things that cause blood clots Reports of COVID-19 vaccinations causing blood clots has caused alarm in the general population.
Oncology Treating primary bone cancer: The potential of listeria-base... In a new pharmaphorum podcast, Paul Romness, president and CEO of OS Therapies, discusses the company's work in osteosarcoma.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
